i-Base home
Search Menu
  • Home
  • HTB
  • EACS 9th Warsaw 2003

EACS 9th Warsaw 2003

9th European AIDS Conference (EACS), 25-29 October 2003, Warsaw

1 December 2003. Related: Conference reports.

Lower doses of d4T produce similar efficacy and reduced side effects

1 December 2003. Related: Conference reports, Side effects, Weight, diabetes, metabolic complications.

Interruption of treatment is safe for those who started too early

1 December 2003. Related: Conference reports, Treatment strategies.

T20 is cost effective for UK purchasers

1 December 2003. Related: Conference reports, Antiretrovirals.

Intrauterine exposure to efavirenz

1 December 2003. Related: Conference reports, Women's health, Pregnancy, Side effects.

Five-year results of Kaletra-based therapy in treatment-naïve HIV patients

1 December 2003. Related: Conference reports, Antiretrovirals.

IL-2 effectively increases CD4 count in people with low CD4 nadir

1 December 2003. Related: Conference reports, Basic science and immunology.

Hepatitis coinfection: incidence in Europe and response to transplant

1 December 2003. Related: Conference reports, Hepatitis coinfection.

Rituximab plus CDE for HIV-related Non-Hodgkins Lymphoma (NHL)

1 December 2003. Related: Conference reports, Antiretrovirals, Cancer and HIV.

  • HTB RSS

Early access

  • Closed clinics and limited ART in Zimbabwe, PEPFAR and UNAIDS news 4 May 2025
  • The RIO study: Q&A about controlling HIV with bNAbs 21 April 2025
  • Lenacapavir EAP in the UK closed to new referrals: NHS England and Gilead fail to agree a price after more than two years 20 April 2025
  • Viral failure on CAB/RPV-LA: overcoming drug resistance with second-generation INSTIs 13 April 2025
  • All early access reports

Current issues

  • May 2025
  • April 2025
  • March 2025
  • Back issues

Special report

  • Reduced dosing: a possible crisis response to ART stockouts and closed clinics 5 May 2025

More from HTB

  • Conference reports
  • Conference shortcuts
  • Articles by subject
  • PDFs
  • Subscribe
  • HTB homepage

Home

  • i-Base homepage
  • Donate

This website sets no cookies from us or anyone else.

Information on this website is provided by treatment advocates and offered as a guide only. Decisions about your treatment should always be taken in consultation with your doctor.

HIV i-BASE
About us - Contact - Cookies and privacy - Copyright waiver - Terms of use - Home
Registered charity number: 1081905. Company number: 3962064.

Search i-Base

Site navigation

Quick links
HIV positive
Donate
Feedback
Advice and information
Q and A
Guides
HIV meds
Glossary
Research reports
HTB
HTB South
Pipeline report
Publications and resources
Publications
Other resources
Translations
Slide sets
Order and subscribe
Advocates' network
UK-CAB
Training manual
i-Base
About us
Contact
News and updates
Sitemap
Home
Find us on Facebook
i-Base on Facebook